Drozdz Dorota, Pietrzyk Jacek A, Wierzchowska-Słowiaczek Ewa, Sancewicz-Pach Krystyna, Antignac Corinne, Miezyński Witold
Collegium Medicum, Uniwersytetu Jagiellońskiego w Krakowie.
Przegl Lek. 2006;63 Suppl 3:85-6.
Within recent years the number of children with focal segmental glomerulonephritis (FSGS) has increased. A significant progress in defining of molecular basis of the disease has been made. Gene mutations for nephrin, podocin, WT1, alpha-actinin 4 cause the damage of filtration barrier of glomerulus and proteinuria in consequence. A girl (S.G.) became ill at the age of 3.5, suffering form steroid-resistant nephritic syndrome (SRNS) with microscopic hematuria. The renal biopsy showed FSGS accompanied by a complete diffuse effacement of podocyte food processes. Despite intensive and regular immunosuppressive therapy, remission was not achieved. In the control renal biopsy performed a year after cyclosporin A had been applied, 50% of globally sclerosed glomeruli as well as some features of post-cyclosporin damage were found. The girl required renal replacement therapy at the age of 10.5. Dialyzed at the adult dialysis centre she died at the age of 11.5. A boy S.P. was diagnosed with SRNS when he was 11.5 years old. The renal biopsy was performed after one month of treatment and showed mesangial proliferation and diffuse effacement of podocyte food processes. After chlorambucil treatment remission was not achieved, and after methylprednisolon pulse therapy only the reduction of proteinuria was achieved. In a control renal biopsy 10 out of 13 glomeruli were globally sclerosed. At the age of 17 the patient showed chronic renal failure with a fast progression of the disease. In September 2000 the boy started renal replacement therapy, an in June 2001 he received a renal transplant without the recurrence of FGS. In 2001 a heterozygous mutation (A284V) in gene NPHS2 was found in both of the siblings. Within the confines of the clinical project ESCAPE Trial another genetic examination was performed. In the boy one missense mutation on one allele (A284V) and the R229Q polymorphism on the other allele were found. In this family the father is bear. ing the A284V mutation and the mother the R229Q variant. These results prove that this disease is due to alterations of the podocin gene in the described family.
近年来,局灶节段性肾小球肾炎(FSGS)患儿的数量有所增加。在确定该疾病的分子基础方面已取得重大进展。nephrin、podocin、WT1、α -辅肌动蛋白4的基因突变会导致肾小球滤过屏障受损,进而引发蛋白尿。一名女孩(S.G.)在3.5岁时患病,患有激素抵抗性肾病综合征(SRNS)并伴有镜下血尿。肾活检显示为FSGS,伴有足细胞足突完全弥漫性消失。尽管进行了强化且规律的免疫抑制治疗,但仍未实现缓解。在应用环孢素A一年后进行的对照肾活检中,发现50%的肾小球全球硬化以及一些环孢素后损伤的特征。该女孩在10.5岁时需要进行肾脏替代治疗。在成人透析中心进行透析后,她于11.5岁去世。一名男孩S.P.在11.5岁时被诊断为SRNS。治疗一个月后进行肾活检,显示系膜增生和足细胞足突弥漫性消失。使用苯丁酸氮芥治疗后未实现缓解,甲基强的松龙冲击治疗后仅实现了蛋白尿的减少。在对照肾活检中,13个肾小球中有10个全球硬化。17岁时,该患者出现慢性肾衰竭,疾病进展迅速。2000年9月,该男孩开始进行肾脏替代治疗,2001年6月接受了肾脏移植,未出现FSGS复发。2001年,在这对姐弟中均发现了NPHS2基因的杂合突变(A284V)。在临床项目ESCAPE试验范围内进行了另一项基因检测。在该男孩中,一个等位基因上发现一个错义突变(A284V),另一个等位基因上发现R229Q多态性。在这个家庭中,父亲携带A284V突变,母亲携带R229Q变异。这些结果证明,在所描述的这个家庭中,该疾病是由于podocin基因的改变所致。